Publication | Closed Access
Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study
87
Citations
41
References
2005
Year
The combination of orlistat and micronised fenofibrate appears to be safe and may further improve metabolic parameters in overweight and obese patients with MetS compared with each monotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1